Sanofi Submits U300 Insulin to FDA

(MedPage Today) -- The FDA has accepted Sanofi's new drug application for an upgraded formulation of its insulin glargine (Lantus), which is set to come off patent next year.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news